Two months after we broke the story that Forma Therapeutics had axed R&D staff in a major reorganization of the company, founding CEO Steve Tregay is now joining the exodus. He’s being replaced at the helm by Genentech vet and chief strategy officer Frank Lee. While Tregay confirmed to me in January that Forma had … Continue reading $757M and 5 years later, Celgene abandoned a biotech partner, triggering layoffs